Trigeminal nerve branch (specify ophthalmic, maxillary, or mandibular if possible) (CN V1 (Ophthalmic), CN V2 (Maxillary), CN V3 (Mandibular))

The trigeminal nerve branch refers to one of the three main subdivisions of the trigeminal nerve (CN V), which is the principal sensory nerve of the face and also provides motor innervation to the muscles of mastication. The three branches (ophthalmic, maxillary, mandibular) transmit sensory information (touch, pain, temperature) from distinct regions of the face and oral cavity, and the mandibular branch also mediates motor functions for chewing. These branches are anatomical structures, not molecular drug targets, but can be involved in disease processes (especially trigeminal neuralgia) and are sometimes targeted by medical or surgical therapies for pain control, including ion-channel targeting drugs and CGRP pathway inhibitors for migraine. Note: "Trigeminal nerve branch" is not a canonical molecular target—it's an anatomical term denoting one of three divisions of a nerve; the precise branch (V1, V2, V3) should be specified for clarity. The real molecular drug targets relevant to trigeminal pain are typically ion channels or neuropeptide receptors involved in the trigeminal pathways (such as CGRP receptor), not the nerve branch itself.

Other names

Trigeminal branchCN V branchOphthalmic nerve (V1)Maxillary nerve (V2)Mandibular nerve (V3)

Blockade of voltage-gated ion channels (anti-epileptics decrease pain signaling); Inhibition of CGRP signaling (monoclonal antibodies and receptor antagonists); Inhibition of neuromuscular transmission (botulinum toxin); Local anesthetic blockade (lidocaine inhibits axonal conduction)